Abstract
The convergence of nanoscience and nucleotide delivery holds tremendous
promise in revolutionizing diabetes treatment. Nucleotide delivery emerged as a
promising tool to modulate gene expression and cellular function in diabetes.
Integration of nanoscience and nucleotide delivery in diabetes treatment opens avenues
for efficient therapies. This approach has the potential to significantly improve glucose
regulation and mitigate long-term complications associated with the disease. This
chapter discussed DNA and RNA delivery approaches in diabetes treatment and the
future and challenges of nucleotide delivery in diabetes.
Keywords: Delivery, Diabetes, Gene, Nanotechnology.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Diabetes Reviews
Current Neurovascular Research
Current Respiratory Medicine Reviews
Current Pediatric Reviews
Infectious Disorders - Drug Targets
Current Stem Cell Research & Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Aging Science
Anti-Infective Agents
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents